{"id":277029,"date":"2026-09-29T11:14:55","date_gmt":"2026-09-29T05:44:55","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=277029"},"modified":"2026-09-29T11:14:55","modified_gmt":"2026-09-29T05:44:55","slug":"why-syncom-formulations-india-ltd-share-price-rise-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/","title":{"rendered":"Syncom Formulations (India) Ltd. (SYNCOMF): Syncom Formulations Share Price rises 9.73% as stock gains today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/syncomf\/syncom-formulations-(india)-ltd-share-price-today\">Syncom Formulations (India) Ltd. (SYNCOMF)<\/a> share price rose to Rs 24.36 today, up 9.73% from the previous close. Market cap was Rs 1,885.64 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Syncom Formulations Share Price is Rs 24.36 today, up 9.73% from the previous close of Rs 22.20, with market capitalisation at Rs 1,885.64 crore. The latest Univest figures show a clear price rise in early trade, but no company-specific catalyst is established. For readers tracking Syncom Formulations Share Price Today, the move is notable because it lifts the stock into the day\u2019s top gainers conversation while keeping the focus on verified price action, valuation and healthcare sector context. According to Univest data, the price event is confirmed, and the next useful checkpoints are the day\u2019s range, valuation multiples and how the stock compares with listed pharmaceutical peers. Syncom Formulations Share Price News therefore centres on what changed in the market today rather than on any unverified trigger.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Syncom_Formulations_Share_Price_Today_Price_Action_Analysis\" title=\"Syncom Formulations Share Price Today: Price Action Analysis\">Syncom Formulations Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Syncom_Formulations_India_Ltd_SYNCOMF_Fundamental_Analysis\" title=\"Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis\">Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Why_Investors_Are_Watching_Syncom_Formulations\" title=\"Why Investors Are Watching Syncom Formulations\">Why Investors Are Watching Syncom Formulations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#About_Syncom_Formulations\" title=\"About Syncom Formulations\">About Syncom Formulations<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Why_is_Syncom_Formulations_Share_Price_rising_today\" title=\"Why is Syncom Formulations Share Price rising today?\">Why is Syncom Formulations Share Price rising today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#What_is_Syncom_Formulations_Share_Price_today\" title=\"What is Syncom Formulations Share Price today?\">What is Syncom Formulations Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#How_much_did_Syncom_Formulations_Share_Price_gain_today\" title=\"How much did Syncom Formulations Share Price gain today?\">How much did Syncom Formulations Share Price gain today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#What_is_Syncom_Formulations_Share_Price_market_capitalisation\" title=\"What is Syncom Formulations Share Price market capitalisation?\">What is Syncom Formulations Share Price market capitalisation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Is_Syncom_Formulations_Share_Price_expensive_compared_with_peers\" title=\"Is Syncom Formulations Share Price expensive compared with peers?\">Is Syncom Formulations Share Price expensive compared with peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#What_does_Syncom_Formulations_Share_Price_fundamental_analysis_show\" title=\"What does Syncom Formulations Share Price fundamental analysis show?\">What does Syncom Formulations Share Price fundamental analysis show?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#How_does_Syncom_Formulations_Share_Price_compare_with_the_sector\" title=\"How does Syncom Formulations Share Price compare with the sector?\">How does Syncom Formulations Share Price compare with the sector?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Should_investors_track_Syncom_Formulations_Share_Price_now\" title=\"Should investors track Syncom Formulations Share Price now?\">Should investors track Syncom Formulations Share Price now?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-syncom-formulations-india-ltd-share-price-rise-today-2026\/#Track_Syncom_Formulations_Share_Price_on_Univest\" title=\"Track Syncom Formulations Share Price on Univest\">Track Syncom Formulations Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Syncom_Formulations_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Syncom Formulations Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 24.36<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 22.2<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2.16 (+9.73%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 22.36<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 24.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 22.06<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,885.64 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Small Cap<\/td>\n<\/tr>\n<\/table>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) rose to Rs 24.36 from the previous close of Rs 22.2, a move of Rs 2.16 or 9.73%. The stock opened at Rs 22.36, reached a high of Rs 24.85, recorded a low of Rs 22.06.<\/p>\n<p>Syncom Formulations Share Price is trading at Rs 24.36, up Rs 2.16 or 9.73% from the previous close. The stock opened at Rs 22.36, touched a high of Rs 24.85 and a low of Rs 22.06, which places the current price near the upper end of today\u2019s range. That is the core price action story behind Syncom Formulations Share Price today: a strong rise from the prior close, an opening above yesterday\u2019s level and an intraday move that has stayed firm through the morning. Univest figures confirm the price action, but they do not point to a specific company trigger. For anyone following Syncom Formulations Share Price Live, the immediate reference points remain Rs 24.36, Rs 22.20 and the day\u2019s range. The move also keeps Syncom Formulations Share Price in focus across Stock Market Today and Share Market Today screens. The next section shifts from price action to fundamental analysis.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Syncom_Formulations_India_Ltd_SYNCOMF_Fundamental_Analysis\"><\/span><strong>Syncom Formulations (India) Ltd. (SYNCOMF) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,885.64 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">24.4x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.74x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.19%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.91<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 4.68<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.45%<\/td>\n<\/tr>\n<\/table>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) fundamental metrics show P\/E 24.4x, P\/B 4.74x, ROE 20.19%, ROCE 26.8%. Taken on their own, these numbers offer context rather than a trading signal.<\/p>\n<p>Syncom Formulations (India) Ltd. has a market capitalisation of Rs 1,885.64 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 24.4x, P\/B at 4.74x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 20.19% and ROCE of 26.8%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 0.91, book value per share of Rs 4.68, dividend yield of 0.45%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 32.59x, median ROE of 11.7%, median ROCE of 13.61%. They set out the fundamental picture and are not a rating on the stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">24.4x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.59x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.46x to 707.31x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.74x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.88x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.19%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.8%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.61%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,885.64 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 783.26 crore<\/td>\n<\/tr>\n<\/table>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) operates in the Healthcare sector, within the Pharmaceuticals &amp; Drugs industry.<\/p>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) has a P\/E ratio of 24.4x, which is below the benchmark median of 32.59x, a difference of -25.13%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) has a ROE of 20.19%, which is above the benchmark median of 11.7%, a difference of +72.56%. Syncom Formulations (India) Ltd. (SYNCOMF) has a ROCE of 26.8%, which is above the benchmark median of 13.61%, a difference of +96.91%.<\/p>\n<p>Track stocks leading today through the <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,44,716.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.1<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><strong>Divi&#39;s Laboratories Ltd.<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,55,115.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.33<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,89,613.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">84.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.64<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,19,899.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.79<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,12,875.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Syncom Formulations (India) Ltd. (SYNCOMF) has a P\/E ratio of 24.4x compared with the displayed peer median of 36.5x. The comparison is relative and should not be read as a recommendation. Its ROE of 20.19% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 26.8% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Syncom Formulations (India) Ltd. (SYNCOMF) has a market capitalisation of Rs 1,885.64 crore. All 5 peers shown have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Syncom_Formulations\"><\/span><strong>Why Investors Are Watching Syncom Formulations<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Syncom Formulations Share Price rose 9.73% today and is trading near the upper part of the day\u2019s range.<\/li>\n<li>The latest Univest figures show PE, PB, ROE, ROCE, EPS, book value and dividend yield all in one view for Syncom Formulations Share Price.<\/li>\n<li>Syncom Formulations Share Price trades below the industry median PE but above the industry median PB in healthcare sector analysis.<\/li>\n<li>ROE and ROCE for Syncom Formulations Share Price are above the industry median, which adds context to the move.<\/li>\n<li>Syncom Formulations Stock News is also relevant because the stock is moving without a verified company-specific catalyst.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Syncom_Formulations\"><\/span><strong>About Syncom Formulations<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Syncom Formulations Share Price represents Syncom Formulations (India) Ltd., a company in the Healthcare sector and the Pharmaceuticals &#038; Drugs industry. The business context matters because Syncom Formulations Share Price is often read through the lens of company overview, company financials and sector analysis rather than only through one trading move. The company operates in pharmaceuticals and drugs, which places it in an industry where valuation, return ratios and market capitalisation are closely watched. Syncom Formulations Share Price today reflects that broader setup: a smaller listed pharmaceutical company with measurable profitability ratios, a defined sector position and active comparison against listed peers. For readers following Syncom Formulations Stock Analysis, the company\u2019s identity, industry and return profile are the main reference points available from Univest. That makes Syncom Formulations Share Price useful for investors who want a factual update on the stock without speculation.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Syncom_Formulations_Share_Price_rising_today\"><\/span><strong>Why is Syncom Formulations Share Price rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations Share Price is rising today because the stock is up 9.73% to Rs 24.36. Univest figures confirm the price action, but they do not point to a specific company trigger.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Syncom_Formulations_Share_Price_today\"><\/span><strong>What is Syncom Formulations Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations Share Price today is Rs 24.36. It is higher than the previous close of Rs 22.20 and has moved within a day\u2019s range of Rs 22.06 to Rs 24.85.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_did_Syncom_Formulations_Share_Price_gain_today\"><\/span><strong>How much did Syncom Formulations Share Price gain today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations Share Price gained Rs 2.16, which is a 9.73% rise from the previous close. That makes it one of the sharper price moves in today\u2019s market update.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Syncom_Formulations_Share_Price_market_capitalisation\"><\/span><strong>What is Syncom Formulations Share Price market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations Share Price has a market capitalisation of Rs 1,885.64 crore. That places the company above the industry median market cap of Rs 783.26 crore in the same industry benchmark.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Syncom_Formulations_Share_Price_expensive_compared_with_peers\"><\/span><strong>Is Syncom Formulations Share Price expensive compared with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations Share Price trades at a PE of 24.4 and PB of 4.74. Its PE is below several major peers, while PB is above the industry median, so valuation needs a ratio-by-ratio view.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Syncom_Formulations_Share_Price_fundamental_analysis_show\"><\/span><strong>What does Syncom Formulations Share Price fundamental analysis show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations Share Price shows ROE of 20.19%, ROCE of 26.8%, EPS of Rs 0.91, book value of Rs 4.68 and dividend yield of 0.45%, which together frame the fundamental view.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Syncom_Formulations_Share_Price_compare_with_the_sector\"><\/span><strong>How does Syncom Formulations Share Price compare with the sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Syncom Formulations Share Price has a PE below the industry median and ROE and ROCE above the industry median. That combination gives the stock a different profile within Healthcare and Pharmaceuticals &amp; Drugs.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_investors_track_Syncom_Formulations_Share_Price_now\"><\/span><strong>Should investors track Syncom Formulations Share Price now?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors tracking Syncom Formulations Share Price may watch how the current rise holds against the day\u2019s range, valuation ratios and peer comparison. Univest keeps the latest numbers together for quick review.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why is Syncom Formulations Share Price rising today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Syncom Formulations Share Price is rising today because the stock is up 9.73% to Rs 24.36. Univest figures confirm the price action, but they do not point to a specific company trigger.\"}},{\"@type\":\"Question\",\"name\":\"What is Syncom Formulations Share Price today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Syncom Formulations Share Price today is Rs 24.36. It is higher than the previous close of Rs 22.20 and has moved within a day\u2019s range of Rs 22.06 to Rs 24.85.\"}},{\"@type\":\"Question\",\"name\":\"How much did Syncom Formulations Share Price gain today?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Syncom Formulations Share Price gained Rs 2.16, which is a 9.73% rise from the previous close. That makes it one of the sharper price moves in today\u2019s market update.\"}},{\"@type\":\"Question\",\"name\":\"What is Syncom Formulations Share Price market capitalisation?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Syncom Formulations Share Price has a market capitalisation of Rs 1,885.64 crore. That places the company above the industry median market cap of Rs 783.26 crore in the same industry benchmark.\"}},{\"@type\":\"Question\",\"name\":\"Is Syncom Formulations Share Price expensive compared with peers?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Syncom Formulations Share Price trades at a PE of 24.4 and PB of 4.74. Its PE is below several major peers, while PB is above the industry median, so valuation needs a ratio-by-ratio view.\"}},{\"@type\":\"Question\",\"name\":\"What does Syncom Formulations Share Price fundamental analysis show?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Syncom Formulations Share Price shows ROE of 20.19%, ROCE of 26.8%, EPS of Rs 0.91, book value of Rs 4.68 and dividend yield of 0.45%, which together frame the fundamental view.\"}},{\"@type\":\"Question\",\"name\":\"How does Syncom Formulations Share Price compare with the sector?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Syncom Formulations Share Price has a PE below the industry median and ROE and ROCE above the industry median. That combination gives the stock a different profile within Healthcare and Pharmaceuticals & Drugs.\"}},{\"@type\":\"Question\",\"name\":\"Should investors track Syncom Formulations Share Price now?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Investors tracking Syncom Formulations Share Price may watch how the current rise holds against the day\u2019s range, valuation ratios and peer comparison. Univest keeps the latest numbers together for quick review.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_Syncom_Formulations_Share_Price_on_Univest\"><\/span><strong>Track Syncom Formulations Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/syncomf\/syncom-formulations-(india)-ltd-share-price-today\">Syncom Formulations (India) Ltd. (SYNCOMF) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/top-gainers\">Univest top gainers screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top-gainers lists and related market analysis.<\/p>\n<p>Investors tracking Syncom Formulations Share Price can use Univest to monitor live share price, market capitalisation, fundamental ratios, 52-week levels and market insights in one place. Syncom Formulations Share Price Today can be reviewed alongside PE, PB, ROE, ROCE, EPS, book value and dividend yield, which helps readers compare price action with company financials. Univest also keeps Syncom Formulations Stock News and Syncom Formulations Share News in a single research view for quick reference.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Syncom Formulations (India) Ltd. Share Price rises to Rs 24.36, marking a 9.73% rise today. Market cap stands at Rs 1,885.64 crore.<\/p>\n","protected":false},"author":35,"featured_media":277023,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-277029","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["277023"],"rank_math_title":["Syncom Formulations Share Price: 9.73% rise and valuation"],"rank_math_description":["Syncom Formulations Share Price rose 9.73% to Rs 24.36. Read price action, valuation, sector context and peer comparison for Syncom today."],"rank_math_focus_keyword":["Syncom Formulations Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Syncom_Formulations_India_Ltd_SYNCOMF_Syncom_Formulations_Share_Price_rises_973_as_stock_gains_today_bullish.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/277029","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=277029"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/277029\/revisions"}],"predecessor-version":[{"id":277035,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/277029\/revisions\/277035"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/277023"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=277029"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=277029"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=277029"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}